Free cash flow
Roivant Sciences Free cash flow increased by 13.8% to -$165.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.8%, from -$173.38M to -$165.08M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows relatively stable performance with a 2.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$143.51M | -$123.36M | -$274.57M | -$153.73M | -$259.54M | -$192.73M | -$223.10M | -$180.71M | -$250.34M | -$196.70M | -$210.81M | -$108.81M | -$193.79M | -$267.80M | -$209.08M | -$173.38M | -$208.42M | -$193.51M | -$191.55M | -$165.08M |
| QoQ Change | — | +14.0% | -122.6% | +44.0% | -68.8% | +25.7% | -15.8% | +19.0% | -38.5% | +21.4% | -7.2% | +48.4% | -78.1% | -38.2% | +21.9% | +17.1% | -20.2% | +7.2% | +1.0% | +13.8% |
| YoY Change | — | — | — | — | -80.9% | -56.2% | +18.7% | -17.5% | +3.5% | -2.1% | +5.5% | +39.8% | +22.6% | -36.1% | +0.8% | -59.3% | -7.5% | +27.7% | +8.4% | +4.8% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's free cash flow?
- Roivant Sciences (ROIV) reported free cash flow of -$165.08M in Q1 2026.
- How has Roivant Sciences's free cash flow changed year-over-year?
- Roivant Sciences's free cash flow increased by 4.8% year-over-year, from -$173.38M to -$165.08M.
- What is the long-term trend for Roivant Sciences's free cash flow?
- Over 4 years (2021 to 2025), Roivant Sciences's free cash flow has grown at a 2.2% compound annual growth rate (CAGR), from -$695.17M to -$758.56M.
- What does free cash flow mean?
- The cash remaining after a company pays for its operating expenses and capital investments.